Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Eirini Vasarmidi"'
Autor:
Eirini Vasarmidi, Irini Lambiri, Eirini Foteinaki, Vaia Stamatopoulou, Ioanna Mitrouska, Georgios Pitsidianakis, Alexandros Patrianakos, Anthoula Plevritaki, Stylianos Michelakis, Vasilis Amargianitakis, Georgios Prinianakis, Sophia Schiza, Nikolaos Tzanakis
Publikováno v:
Breathe, Vol 20, Iss 2 (2024)
Externí odkaz:
https://doaj.org/article/fa689702cf684f3f856ca1948398aa42
Publikováno v:
Canadian Respiratory Journal, Vol 2024 (2024)
Hypersensitivity pneumonitis (HP) is a complex interstitial lung disease caused by chronic inhalation of a wide variety of antigens in susceptible and sensitized individuals, commonly associated with an occupational exposure. An impressive number of
Externí odkaz:
https://doaj.org/article/a00eef364d5d4625ae65071691a2f86e
Autor:
Andreas M. Matthaiou, Nikoleta Bizymi, Konstantinos Pagonidis, Eirini Manousaki, Michail Fragkoulakis, Irini Lambiri, Ioanna Mitrouska, Eirini Vasarmidi, Nikolaos Tzanakis, Katerina M. Antoniou
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 2, p 161 (2024)
Coronavirus disease 2019 (COVID-19) pneumonia is associated with extensive pulmonary microangiopathy and the enlargement of the pulmonary artery (PA), while its progression after the remission of the disease has not been investigated yet. The aim was
Externí odkaz:
https://doaj.org/article/018ad7ce2d5a497ea0633d3979d6a6df
Autor:
Theodoros Karampitsakos, Vasilios Tzilas, Ourania Papaioannou, Serafeim Chrysikos, Eirini Vasarmidi, Pierre-Antoine Juge, Styliani Vizirianaki, Eleni Bibaki, Argyro Reppa, Prodromos Sidiropoulos, Matthaios Katsaras, Vasilina Sotiropoulou, Panagiota Tsiri, Electra Koulousousa, Eva Theochari, Georgios Tsirikos, Ioannis Christopoulos, Elli Malakounidou, Eirini Zarkadi, Fotios Sampsonas, Georgios Hillas, Theofanis Karageorgas, Dimitrios Daoussis, Christina Kalogeropoulou, Katerina Dimakou, Nikolaos Tzanakis, Raphael Borie, Philippe Dieudé, Katerina Antoniou, Bruno Crestani, Demosthenes Bouros, Argyris Tzouvelekis
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
IntroductionMyositis associated interstitial lung disease (ILD) seems to be an under-recognized entity.MethodsIn this multicenter, retrospective study, we recorded between 9/12/2019 and 30/9/2021 consecutive patients who presented in five different I
Externí odkaz:
https://doaj.org/article/e4f986e3455643bc85e6e8b48da6c7a3
Autor:
Theodoros Karampitsakos, Sebastiano Torrisi, Katerina Antoniou, Effrosyni Manali, Ioanna Korbila, Ourania Papaioannou, Fotios Sampsonas, Matthaios Katsaras, Eirini Vasarmidi, Despoina Papakosta, Kalliopi Domvri, Eva Fouka, Ioannis Organtzis, Zoe Daniil, Ilias Dimeas, Paraskevi Kirgou, Konstantinos I. Gourgoulianis, Ilias C. Papanikolaou, Katerina Markopoulou, Georgia Kounti, Eirini Tsapakidou, Efthymia Papadopoulou, Konstantinos Tatsis, Athena Gogali, Konstantinos Kostikas, Vasilios Tzilas, Serafeim Chrysikos, Spyridon Papiris, Demosthenes Bouros, Michael Kreuter, Argyrios Tzouvelekis
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) represents a chronic lung disease with unpredictable course. Methods We aimed to investigate prognostic performance of complete blood count parameters in IPF. Treatment-naïve patients with IPF
Externí odkaz:
https://doaj.org/article/58797cb815d347e8ac59a2f2cb5280c4
Autor:
Eliza Tsitoura, Eirini Vasarmidi, Eleni Bibaki, Athina Trachalaki, Chara Koutoulaki, George Papastratigakis, Sevasti Papadogiorgaki, George Chalepakis, Nikos Tzanakis, Katerina M. Antoniou
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-16 (2019)
Abstract Background Impaired mitochondria homeostasis and function are established hallmarks of aging and increasing evidence suggests a link with lung fibrosis. Mitochondria homeostasis may be also affected in alveolar macrophages (AMs) in idiopathi
Externí odkaz:
https://doaj.org/article/ffe638d991294f0f9ca0f3c76805b98e
Autor:
Eliza Tsitoura, Athina Trachalaki, Eirini Vasarmidi, Semeli Mastrodemou, George A. Margaritopoulos, Maria Kokosi, Dionysios Fanidis, Apostolos Galaris, Vassilis Aidinis, Elizabeth Renzoni, Nikos Tzanakis, Athol U. Wells, Katerina M. Antoniou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF) and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of progression despite management. This group of patients has been colle
Externí odkaz:
https://doaj.org/article/db8b3a2a2f2d4bf09d7b6d455f17bed9
Autor:
Nikoleta Bizymi, Georgios Pitsidianakis, Despo Ierodiakonou, Georgios Stathakis, Eirini Vasarmidi, Stavroti Hiraki, Maria Bolaki, Konstantinos Karagiannis, Michail Fanaridis, Konstantinos Liopyrakis, Leonidas Marinos, Irini Xilouri, Katerina M. Antoniou, Nikolaos Tzanakis
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Acute fibrinous and organizing pneumonia (AFOP) is an entity that can be secondary to various conditions leading to lung injury, such as infections, malignancies, and various autoimmune conditions or idiopathic interstitial lung disease, when no obvi
Externí odkaz:
https://doaj.org/article/f9a47137b8a14851b0cfb81426e27739
Autor:
Athina Trachalaki, Eliza Tsitoura, Semeli Mastrodimou, Rachele Invernizzi, Eirini Vasarmidi, Eleni Bibaki, Nikolaos Tzanakis, Philip L. Molyneaux, Toby M. Maher, Katerina Antoniou
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Fibrotic Interstitial lung diseases (ILDs) are complex disorders of variable clinical behaviour. The majority of them cause significant morbidity, whilst Idiopathic Pulmonary Fibrosis (IPF) is recognised as the most relentless. NLRP3, AIM2, and NLRC4
Externí odkaz:
https://doaj.org/article/b296acba02374e95aa7cccea67198371
Autor:
George A. Margaritopoulos, Athina Trachalaki, Athol U. Wells, Eirini Vasarmidi, Eleni Bibaki, George Papastratigakis, Stathis Detorakis, Nikos Tzanakis, Katerina M. Antoniou
Publikováno v:
BMC Pulmonary Medicine, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Pirfenidone is an antifibrotic compound approved for the treatment of idiopathic pulmonary fibrosis (IPF). We present our real-world experience in terms of Pirfenidone’s effect on mortality and adverse events profile outside the
Externí odkaz:
https://doaj.org/article/c64c732659604ca0be6458d87bcda818